Long-Term Adherence to Evidence Based Secondary Prevention Therapies after Acute Myocardial Infarction

被引：0
|
作者：
Ayse Akincigil
John R. Bowblis
Carrie Levin
Saira Jan
Minalkumar Patel
Stephen Crystal
机构：
[1] Rutgers,School of Social Work
[2] The State University of New Jersey,Center for Health Services Research on Pharmacotherapy, Chronic Disease Management, and Outcomes, Institute for Health, Health Care Policy and Aging Research
[3] Rutgers,Ernest Mario School of Pharmacy
[4] The State University of New Jersey,undefined
[5] Rutgers University,undefined
[6] Horizon Blue Cross Blue Shield of New Jersey,undefined
[7] Horizon Healthcare Insurance Company of New York,undefined
来源：
Journal of General Internal Medicine | 2008年 / 23卷
关键词：
acute myocardial infarction; adherence; beta-blockers; angiotensin converting enzyme inhibitors (ACEI); secondary prevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：115 / 121
页数：6
相关论文
共 50 条
  • [1] Long-term adherence to evidence based secondary prevention therapies after acute myocardial infarction
    Akincigil, Ayse
    Bowblis, John R.
    Levin, Carrie
    Jan, Saira
    Patel, Minalkumar
    Crystal, Stephen
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 (02) : 115 - 121
  • [2] Long-term secondary prevention of acute myocardial infarction, guidelines adherence and outcome
    Ergatoudes, C.
    Thunstrom, E.
    Rosengren, A.
    Bjorck, L.
    Bostrom, K. Bengtsson
    Falk, K.
    Fu, M.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1388 - 1389
  • [3] Long-term secondary prevention of acute myocardial infarction (SEPAT) – guidelines adherence and outcome
    Constantinos Ergatoudes
    Erik Thunström
    Annika Rosengren
    Lena Björck
    Kristina Bengtsson Boström
    Kristin Falk
    Michael Fu
    BMC Cardiovascular Disorders, 16
  • [4] Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome
    Ergatoudes, Constantinos
    Thunstrom, Erik
    Rosengren, Annika
    Bjorck, Lena
    Bostrom, Kristina Bengtsson
    Falk, Kristin
    Fu, Michael
    BMC CARDIOVASCULAR DISORDERS, 2016, 16
  • [5] Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction
    Sigrun Halvorsen
    Jarle Jortveit
    Pål Hasvold
    Marcus Thuresson
    Erik Øie
    BMC Cardiovascular Disorders, 16
  • [6] Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction
    Halvorsen, Sigrun
    Jortveit, Jarle
    Hasvold, Pal
    Thuresson, Marcus
    Oie, Erik
    BMC CARDIOVASCULAR DISORDERS, 2016, 16
  • [7] Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease
    Newby, LK
    LaPointe, NMA
    Chen, AY
    Kramer, JM
    Hammill, BG
    DeLong, ER
    Muhlbaier, LH
    Califf, RM
    CIRCULATION, 2006, 113 (02) : 203 - 212
  • [8] Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction
    Rasmussen, Jeppe N.
    Chong, Alice
    Alter, David A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (02): : 177 - 186
  • [9] Summary of the recommendations for long-term secondary prevention after myocardial infarction
    Ostadal, Petr
    Taborsky, Milos
    Linhart, Ales
    Vrablik, Michal
    Ceska, Richard
    Cifkova, Renata
    Kralikova, Eva
    Adamkova, Vera
    Kvapil, Milan
    Jojko, Zorjan
    COR ET VASA, 2019, 61 (05) : 471 - 480
  • [10] Antiplatelet Therapy for Long-term Secondary Prevention After Myocardial Infarction
    Bonaca, Marc P.
    Sabatine, Marc S.
    JAMA CARDIOLOGY, 2016, 1 (06) : 627 - 628
12345